Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting250%
terminated125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

NCT06321965
terminated

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer

NCT05803889
recruiting

Natural History Study of Children With LAMA2-related Dystrophies

NCT06354790
completednot_applicable

Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease

NCT01440075

Clinical Trials (4)

Showing 4 of 4 trials
NCT06321965Not Applicable

Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy

Recruiting
NCT05803889

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer

Terminated
NCT06354790

Natural History Study of Children With LAMA2-related Dystrophies

Recruiting
NCT01440075Not Applicable

Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4